Back to 
BlackRock, Inc.
BlackRock, Inc.
BCLI4 quarters
Position history for BlackRock, Inc.'s holdings in BrainStorm Cell Therapeutics In
BlackRock, Inc. previously held 0 shares of BCLI (BrainStorm Cell Therapeutics In), worth $0 as of 2025-Q3.
Final Value
$0
Final Shares
0
Total Value Change
-$57,140
Total Shares Change
-25,172
Quarter-by-Quarter History
Other major holders of BCLI: VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, HRT FINANCIAL LP